Loading company…
Molecular Staging develops technologies to detect and quantify proteins and nucleic acids.
Molecular Staging develops diagnostic technologies to detect and quantify proteins and nucleic acids, including biomarkers related to cancer and other diseases. Its offerings include Rolling Circle Amplification Technology, protein microarrays and whole-genome amplification services for researchers and clinical laboratories. Founded in 1998, the company was based in New Haven, US. Qiagen acquired it in September 2004.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in